Modulation of cell proliferation, survival and gene expression by RAGE and TLR signaling in cells of the innate and adaptive immune response: role of p38 MAPK and NF-KB


Autoria(s): Medeiros, Marcell Costa de; Tfaile Frasnelli, Sabrina Cruz; Bastos, Alliny de Souza; Orrico, Silvana Regina Perez; Rossa Júnior, Carlos
Contribuinte(s)

Universidade Estadual Paulista (UNESP)

Data(s)

03/12/2014

03/12/2014

01/05/2014

Resumo

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Processo FAPESP: 10/06589-8

Objective: The aim of this study was to evaluate a possible synergism between AGE-RAGE and TLR4 signaling and the role of p38 MAPK and NF-kB signaling pathways on the modulation of the expression of inflammatory cytokines and proliferation of cells from the innate and adaptive immune response. Material and Methods: T lymphocyte (JM) and monocyte (U937) cell lines were stimulated with LPS and AGE-BSA independently and associated, both in the presence and absence of p38 MAPK and NF-kB inhibitors. Proliferation was assessed by direct counting and viability was assessed by a biochemical assay of mitochondrial function. Cytokine gene expression for RAGE, CCL3, CCR5, IL-6 and TNF-alpha was studied by RT-PCR and RT-qPCR. Results: RAGE mRNA expression was detected in both cell lines. LPS and AGE-BSA did not influence cell proliferation and viability of either cell line up to 72 hours. LPS and LPS associated with AGE induced expression of IL-6 and TNF-alpha in monocytes and T cells, respectively. Conclusions: There is no synergistic effect between RAGE and TLR signaling on the expression of IL-6, TNF-alpha, RAGE, CCR5 and CCL3 by monocytes and lymphocytes. Activation of RAGE associated or not with TLR signaling also had no effect on cell proliferation and survival of these cell types.

Formato

185-193

Identificador

http://dx.doi.org/10.1590/1678-775720130593

Journal Of Applied Oral Science. Bauru-sp: Univ Sao Paulo Fac Odontologia Bauru, v. 22, n. 3, p. 185-193, 2014.

1678-7757

http://hdl.handle.net/11449/112501

10.1590/1678-775720130593

S1678-77572014000300185

WOS:000337907600008

S1678-77572014000300185.pdf

Idioma(s)

eng

Publicador

Universidade de São Paulo (USP), Faculdade de Odontologia de Bauru

Relação

Journal of Applied Oral Science

Direitos

openAccess

Palavras-Chave #Periodontal diseases #Diabetes mellitus #Innate immunity #Acquired immunity #Advanced glycosylation end products
Tipo

info:eu-repo/semantics/article